Market Cap: $60.7M
RI
RenovoRx, Inc.
RNXT
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $60.7M
RenovoRx Secures $12.1 Million in Public Offering to Propel Oncology Innovations RenovoRx, Inc., a pioneering life sciences firm focused on oncology therapies, successfully concludes a $12.1 million p…
RenovoRx Secures Funding to Propel Innovative Oncology Therapies RenovoRx, Inc. successfully completes a $12.1 million public offering of common stock, marking a significant step in its pursuit of gro…
RenovoRx Advances Oncology Solutions with New Funding Initiative RenovoRx, Inc., a life sciences company specializing in targeted oncology therapies, announces the launch of an underwritten public off…
RenovoRx Advances Oncology Therapy with New Offering RenovoRx, Inc., a life sciences company based in Mountain View, California, is making significant strides in the oncology sector with the announcem…
RenovoRx Advances Targeted Therapy for Pancreatic Cancer RenovoRx, Inc., a life sciences company specializing in targeted oncology therapies, presents significant advancements in its Trans-Arterial Mi…
RenovoRx Advances Innovative Cancer Treatment with TAMP Therapy Platform RenovoRx, Inc., a life sciences company based in Mountain View, California, is making significant strides in the oncology field…